Diabetic neuropathies
- Authors: Bogdanov E.I.1,2, Talantov V.V.1,2, Mukhamedzyanov R.Z.1,2
-
Affiliations:
- Kazan State Medical University
- Diabetes Center of the Republican Clinical Hospital of the Ministry of Health of the Republic of Tatarstan
- Issue: Vol XXXII, No 3-4 (2000)
- Pages: 59-67
- Section: Articles
- URL: https://journals.rcsi.science/1027-4898/article/view/79487
- DOI: https://doi.org/10.17816/nb79487
- ID: 79487
Cite item
Full Text
Abstract
Diabetic neuropathies (DN) are among the most frequent and serious complications of diabetes [5–7, 9]. The detection rate of DN in diabetic patients varies greatly depending on their type, selected clinical and instrumental diagnostic criteria and, according to various researchers, ranges from 10 to 90% [16, 33]. At the same time, 1/3 of the polyneuropathies recognized in the neurological clinic are diabetic. In about 10% of cases, neuropathic symptoms are key in the diagnosis of diabetes [25]. DN has not only severe subjective manifestations and pronounced impairments that are objectively detected in them, but also leads to the development of diabetic foot syndrome - the cause of 50 - 70% of cases of all non-traumatic amputations of the legs [3]. In addition, in patients with diabetic visceral autonomic neuropathy, the syndrome of "sudden death" is much more common, and the frequency of painless myocardial infarctions and ischemic strokes is high. Clinical variants of DN are often the main causes of reduced quality of life, disability and disability in patients with diabetes mellitus. It is extremely important to diagnose the early stage of DN, when it is easier to achieve a therapeutic effect through the earliest and most stable provision of optimal control of an adequate level of glycemia and the appointment of means of pathogenetic therapy. Isolation of forms of DN, their diagnosis, treatment and prevention is an urgent clinical task.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
E. I. Bogdanov
Kazan State Medical University; Diabetes Center of the Republican Clinical Hospital of the Ministry of Health of the Republic of Tatarstan
Author for correspondence.
Email: info@eco-vector.com
Russian Federation, Kazan; Kazan
V. V. Talantov
Kazan State Medical University; Diabetes Center of the Republican Clinical Hospital of the Ministry of Health of the Republic of Tatarstan
Email: info@eco-vector.com
Russian Federation, Kazan; Kazan
R. Z. Mukhamedzyanov
Kazan State Medical University; Diabetes Center of the Republican Clinical Hospital of the Ministry of Health of the Republic of Tatarstan
Email: info@eco-vector.com
Russian Federation, Kazan; Kazan
References
- Балаболкин М.И. Применение препарата “Мильгамма-100” в комплексной терапии диабетической нейропатии: Метод. рекомендации. — М., 1997. — 20 с.
- Богданов Э.И. //Невролог. вестн. — 1995. — № 3 — 4. — С.28 - 34.
- Галстян Г.Р. //Нов. мед. журн. — 1998. — № 2. — С.16 - 21; № 3. - С.2 - 6.
- Горбачева Ф.Е., Зиновьева О.Е., Королева Т.В. и др. //Невролог. журн. — 2000. — № 1. — С.47 — 49.
- Дедов И.И., Фадеев В.В. Введение в диабетологию: Руководство для врачей. — М., 1998.
- Попелянский Я.Ю. Болезни периферической нервной системы. — М., 1989.
- Прихожан В.М. Поражение нервной системы при сахарном диабете. — М., 1981
- Строков И.А., Козлова Н.А., Мозолевский Ю.В. и др. //Журн. невропатол. и психиатр. — 1999. — № 6. — С. 18 — 22.
- Талантов В.В., Султанова Л.М. Сахарный диабет. — Казань, 1990.
- Талантов В.В. Болезнь инъекция болезнь. — Казань, 1989.
- Аппенцелер О., Аткинсон Р. Болезни вегетативной нервной системы: оценка и лечение //Заболевания периферической нервной системы /Под ред. Эсбери А.К., Джиллиатта Р.У. (пер. с англ.). — М., 1987.
- Baker L., Chambers R., DeMuth S.K. et al. //Diabetes Care. - 1997. - Vol. 20. - P.405 - 412.
- Barohn R., Sahenk Z., Warmolts J.R. et al. //Arch. Neurol. - 1991. - Vol. 48. - P.l130 - 1135.
- Bosh P., Mitsumoto H. //Disorders of peripheral nerves. In: Neurology in Clin. Pract. (Ed. G. Bradley et al.) — 1996. - Vol. 2. - P.1925 - 1930.
- Boulton A.J.M., Kubrusly D.B., Bowker J.H., et al. //Diabet. Med. - 1986. - Vol. 3. - P.335 - 337.
- Dyck P.J., Knotz K.M., Karnes J.L. et al. //Based cohort. Neurology. — 1993. — Vol. 43. — P.817 — 824.
- Ellenberg M. //Diabetes. — 1974. — Vol. 23. — P.418 - 423.
- Ertas M., Sayduyu A., Araс N. et al. //Pain. — 1998. — Vol. 75. - P.257 - 260.
- Feldman E.L., Stevens M.J., Greene D A. //Totowa: Human Press. — 1998. — P.89 — 105
- Feldman E.L., Russel J.W., Sullivan K.A. et al. //Curr. Opin. in Neurol. — 1999 — Vol. 12. — P.553 — 563.
- Garland H.T. //Br. Med. J. - 1955. - Vol. 2. - P. 1287.
- Gorson K.C., Ropher A.H., Adelman L.S. et al. //Muscle & Nerve. - 2000. - Vol. 23. - P.37 - 43.
- Jackson C.S., Barohn R.J. // J. Neurol. Neurosurg. Psychiatr. — 1998. - Vol. 64. - P.785 - 787.
- Jaradeh S.S., Prieto Th.E., Lobeck L.J. //J. Neurol. Neurosurg. Psych. — 1999. — Vol. 67. — P.607 — 612.
- Kempler P. (Ed.). //Neuropathies. Springer. — 1997. — P.2O7.
- Lauria G., McActhur J.C., Honer P.E. et al. // J. Neurol. Neurosurgery Psychiatry. — 1998. — Vol. 65 — P.763 — 766.
- Levin M., O’Neil L. //The diabetic foot. — Mosby Company, St-Lois. — Toronto, 1988
- Pfeifer M.A., Ross M.A., Schrage J.P. et al. //Diabetes Care. - 1993. - Vol. 16. - P.1103 - 1115.
- Pickup J., Williams G. (Ed.). //Textbook of diabetes. — 1997. - Vol. 1, 2.
- Ross M.A. //Med. Clin. North. Amer. — 1993. — Vol. 77. - P.111 - 124.
- Shulz A. //Verh. Dtsch. Ges. Inn. Med. — 1966. — Vol. 72. - P.1171 - 1175.
- Thomas P.K., Jomlinson D.R. //Philadelphia: WB Saunders. — Peripheral neuropathy. — 1993. — Vol. 2. — P.1219 - 1250.
- Watkins P.J., Erdmons M.E. //Textbook of diabetes. — 1997. - Vol. 2. - P.501.
- Watkins P.J., Thomas P.К. // J. Neurol. Neurosurg. Psychiatr. - 1998. - Vol. 65. - P.620 - 633.
- Wunderlich R., Peters E., Bosma J., Armstrong D. //South Med. J. - 1998. - Vol. 91. - P.10, 894 - 898.
- Young R.J. //Textbook of diabetes. — 1997. — Vol. 2. — P.50.2.
- Young M.J., Bready J.L., Veves A. et al. //Diabetes Care. - 1994. - Vol. 17. - P.557 - 561.